Syndax Pharmaceuticals Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
SNDX chart
What traders are saying about $SNDX
Latest postsSyndax Pharmaceuticals Inc news
- Syndax Pharmaceuticals hosts Q3 2026 results call as stock edges higher
Traders Union ·
- Syndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Yahoo Finance ·
- Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026
Yahoo Finance ·
- At 4:30 p.m. ET on Nov. 2, Syndax will host its results call and webcast
Stock Titan ·
- Syndax Pharmaceuticals (SNDX) Set to Announce Quarterly Earnings on Monday
MarketBeat ·
- What Syndax Pharmaceuticals Holders Got Wrong Before The Slide
Simply Wall Street ·
- How Syndax Pharmaceuticals Inc. (SNDX) Affects Rotational Strategy Timing
Stock Traders Daily ·
- Syndax Pharmaceuticals, Inc. Estimates – NASDAQ:SNDX
TradingView ·
- Syndax Pharmaceuticals (SNDX) Could Be 67% Undervalued Following The Failed IPF Trial
Simply Wall Street ·
- Citi Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $57
Moomoo ·
- Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
Yahoo Finance ·
- J&J earnings set ‘negative tone’; Shkreli vs. the FTC
biopharmadive.com ·
Syndax Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $172.4M | $23.7M | $0 | $0 |
| Net income | -$285.4M | -$318.8M | -$209.4M | -$149.3M |
| Diluted EPS | $-3.29 | $-3.72 | $-2.98 | $-2.46 |
| Total assets (year end) | $529.7M | $724.8M | $612.9M | $497.2M |
| Cash and equivalents (year end) | $134.9M | $154.1M | $295.4M | $74.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Syndax Pharmaceuticals Inc
- Ticker
- SNDX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1395937
Frequently asked questions
What exchange is Syndax Pharmaceuticals Inc listed on?
Syndax Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol SNDX.
What industry is Syndax Pharmaceuticals Inc in?
Syndax Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Syndax Pharmaceuticals Inc headquartered?
Syndax Pharmaceuticals Inc's business address on file with the SEC is in New York, NY.
When does Syndax Pharmaceuticals Inc's fiscal year end?
Syndax Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Syndax Pharmaceuticals Inc report?
Syndax Pharmaceuticals Inc reported $172.4M in revenue for calendar year 2025, according to its SEC filings.